895 related articles for article (PubMed ID: 15696987)
1. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
Gold MH; Rao J; Goldman MP; Bridges TM; Bradshaw VL; Boring MM; Guider AN
J Drugs Dermatol; 2005; 4(1):64-70. PubMed ID: 15696987
[TBL] [Abstract][Full Text] [Related]
2. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
[TBL] [Abstract][Full Text] [Related]
4. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
Alirezaï M; Gerlach B; Horvath A; Forsea D; Briantais P; Guyomar M
Eur J Dermatol; 2005; 15(4):274-8. PubMed ID: 16048758
[TBL] [Abstract][Full Text] [Related]
5. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.
Pazoki-Toroudi H; Nilforoushzadeh MA; Ajami M; Jaffary F; Aboutaleb N; Nassiri-Kashani M; Firooz A
Cutan Ocul Toxicol; 2011 Dec; 30(4):286-91. PubMed ID: 21612319
[TBL] [Abstract][Full Text] [Related]
6. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
[TBL] [Abstract][Full Text] [Related]
8. Treatment of inflammatory facial acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study.
Rojanamatin J; Choawawanich P
Dermatol Surg; 2006 Aug; 32(8):991-6; discussion 996-7. PubMed ID: 16918560
[TBL] [Abstract][Full Text] [Related]
9. An open study to determine the efficacy of blue light in the treatment of mild to moderate acne.
Morton CA; Scholefield RD; Whitehurst C; Birch J
J Dermatolog Treat; 2005; 16(4):219-23. PubMed ID: 16249142
[TBL] [Abstract][Full Text] [Related]
10. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
Alexiades-Armenakas M
J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
[TBL] [Abstract][Full Text] [Related]
11. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
Langner A; Sheehan-Dare R; Layton A
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Bowman S; Gold M; Nasir A; Vamvakias G
J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
[TBL] [Abstract][Full Text] [Related]
13. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
[TBL] [Abstract][Full Text] [Related]
14. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
15. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris.
Gold MH; Bradshaw VL; Boring MM; Bridges TM; Biron JA; Carter LN
J Drugs Dermatol; 2004; 3(6 Suppl):S15-9. PubMed ID: 15624737
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acne with topical antibiotics: lessons from clinical studies.
Simonart T; Dramaix M
Br J Dermatol; 2005 Aug; 153(2):395-403. PubMed ID: 16086756
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris.
Touitou E; Godin B; Shumilov M; Bishouty N; Ainbinder D; Shouval R; Ingber A; Leibovici V
J Eur Acad Dermatol Venereol; 2008 May; 22(5):629-31. PubMed ID: 18410627
[No Abstract] [Full Text] [Related]
18. Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris.
Fadel M; Salah M; Samy N; Mona S
J Drugs Dermatol; 2009 Nov; 8(11):983-90. PubMed ID: 19894365
[TBL] [Abstract][Full Text] [Related]
19. A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin.
Tschen E; Jones T
J Drugs Dermatol; 2002 Sep; 1(2):153-7. PubMed ID: 12847739
[TBL] [Abstract][Full Text] [Related]
20. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Tanghetti E; Kircik L; Wilson D; Dhawan S
J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
